| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 04/27/2006 | US20060088541 Formulations that interact with and alter expression of epithelial cell tyrosine kinase |
| 04/27/2006 | US20060088540 Antagonists and methods for inhibiting angiogenesis |
| 04/27/2006 | US20060088538 Specifically recognizing cancer cells such as non-small cell lung cancer, pancreatic cancer and gastric cancer cells; diagnosis and therapy |
| 04/27/2006 | US20060088537 Protein involved in cancer |
| 04/27/2006 | US20060088536 Therapeutic drug using antibody-presenting hollow protein nanoparticles and hollow protein nanoparticles |
| 04/27/2006 | US20060088535 Method for enhancing long-term memory in a subject and uses thereof |
| 04/27/2006 | US20060088534 Human anti-factor ix/ixa antibodies |
| 04/27/2006 | US20060088532 Lymphatic and blood endothelial cell genes |
| 04/27/2006 | US20060088531 Human antibodies against human glycoprotein VI and their use |
| 04/27/2006 | US20060088529 Bispecific monoclonal antibodies to IL-12 and IL-18 |
| 04/27/2006 | US20060088528 Methods and compositions for treating alzheimer's disease |
| 04/27/2006 | US20060088527 Lung tumor polynucleotides, polypeptides, fusion proteins, antigen presenting cells, T-cells and vaccines containing the polypeptide and an immunostimulant; genetic vaccines; improved early detection |
| 04/27/2006 | US20060088526 Humanized anti-CD3 specific antibodies |
| 04/27/2006 | US20060088525 Therapeutic binding molecules |
| 04/27/2006 | US20060088522 Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates |
| 04/27/2006 | US20060088520 Antigen presenting cell targeting conjugate, an antigen presenting cell contacted with such conjugate, their use for vaccination or as medicament, and methods for their production or generation |
| 04/27/2006 | US20060088471 Compounds for enzyme inhibition |
| 04/27/2006 | DE102005049750A1 Immunological absorber for treating inflammations, comprises organic/synthetic polymer substrates, which is covalently bonded to poly/monoclonal antibodies are arranged against to the peptide complement factors and sepsis mediators |
| 04/27/2006 | DE102004051014A1 Chemisch modifizierte Peptidanaloga Chemically modified peptide analogs |
| 04/27/2006 | CA2584512A1 Truncated fragments of alpha-synuclein in lewy body disease |
| 04/27/2006 | CA2584263A1 Chemically modified peptide analogs |
| 04/27/2006 | CA2584028A1 Method for treating tumors using anti-osteopontin antibodies |
| 04/27/2006 | CA2583937A1 Chimeric protein |
| 04/27/2006 | CA2583799A1 Methods for increasing the diversity of monoclonal antibodies produced against an antigen |
| 04/27/2006 | CA2583578A1 Chromatography ligand |
| 04/27/2006 | CA2582113A1 A method of antibody purification |
| 04/27/2006 | CA2581278A1 Methods and materials for the inhibition of transplant rejection |
| 04/26/2006 | EP1650305A1 Mutants of the factor VII activating protease and methods for their detection |
| 04/26/2006 | EP1650221A2 Novel compounds |
| 04/26/2006 | EP1650220A2 Anti-VEGF antibodies |
| 04/26/2006 | EP1650219A1 Human toll homologues |
| 04/26/2006 | EP1649870A2 Treatment of autoimmune diseases with antagonists which bind to B cell surface markers |
| 04/26/2006 | EP1649054A1 Method for diagnosing colorectal cancers |
| 04/26/2006 | EP1649041A2 Multimeric oxidoreductases |
| 04/26/2006 | EP1649005A2 P450 oxygenases and methods of use |
| 04/26/2006 | EP1649001A2 Antibodies and uses thereof |
| 04/26/2006 | EP1648998A2 Specific binding agents to hepatocyte growth factor |
| 04/26/2006 | EP1648940A2 Reducing protein a leaching during protein a affinity chromatography |
| 04/26/2006 | EP1648939A2 Anti-vegf antibodies |
| 04/26/2006 | EP1648935A2 Antagonists and agonists of ldcam and methods of use |
| 04/26/2006 | EP1648927A1 Soluble fragments of the sars-cov spike glycoprotein |
| 04/26/2006 | EP1648513A2 Use of adcc-optimized antibodies for treating weak patients |
| 04/26/2006 | EP1648512A2 Anti-cd19 antibodies |
| 04/26/2006 | EP1648511A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| 04/26/2006 | EP1648510A2 Rg1 antibodies and uses thereof |
| 04/26/2006 | EP1648509A2 Human anti-ngf neutralizing antibodies as selective ngf pathway inhibitors |
| 04/26/2006 | EP1648507A1 Methods and compositions for increasing the efficiency of therapeutic antibodies using nk cell potentiating compounds |
| 04/26/2006 | EP1648506A1 Method for treating synovial sarcoma |
| 04/26/2006 | EP1648503A2 Active or passive immunization against proapoptotic neurotrophins for the treatment or prevention of neurodegenerative deseases |
| 04/26/2006 | EP1648499A2 P. aeruginosa mucoid exopolysaccharide specific binding peptides |
| 04/26/2006 | EP1648487A2 Immunotherapeutics for biodefense |
| 04/26/2006 | EP1648486A2 Use of a pak inhibitor for the treatment of a joint disease |
| 04/26/2006 | EP1648427A2 Compositions and methods including a recombinant human mab that promotes cns remyelination |
| 04/26/2006 | EP1474521B1 An herpes simplex virus complex |
| 04/26/2006 | EP1421377B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 04/26/2006 | EP1187918B1 Tek antagonists |
| 04/26/2006 | EP1147137B1 Methods for generating phosphorylation site-specific immunological reagents |
| 04/26/2006 | EP1107994B1 Monoclonal antibodies against s100 |
| 04/26/2006 | EP1015592B1 Bacillus thuringiensis cryet33 and cryet34 compositions and uses therefor |
| 04/26/2006 | EP1009829B1 Adipocyte-specific protein homologs |
| 04/26/2006 | EP0983302B1 Mutated ScFv-Fragment of the OKT-3 antibody |
| 04/26/2006 | EP0908466B1 Anti-human lect2 antibody, cells producing the same, and method and kit for assaying the same |
| 04/26/2006 | EP0850305B1 Compounds and methods for diagnosis of tuberculosis |
| 04/26/2006 | EP0848614B1 Isolation of microdomains of caveolae and gpi-anchored proteins |
| 04/26/2006 | EP0784686B1 Herpes simplex virus glycoprotein d variants |
| 04/26/2006 | EP0773997B1 Htk ligand |
| 04/26/2006 | CN1764722A Cyclic AMP response element activator proteins and uses related thereto |
| 04/26/2006 | CN1764478A Anti-cancer anthracycline drug-antibody conjugates |
| 04/26/2006 | CN1764476A Composition and method for the treatment and prevention of enteric bacterial infections |
| 04/26/2006 | CN1763217A Preparation method of monoclonal antibody and application thereof |
| 04/26/2006 | CN1763194A 'Osteoclast-inhibitory factor' (ocif),its nucleotide sequence and methods for producing same |
| 04/26/2006 | CN1763103A Dipropyl phthalic acid artificial antigen and its preparation method |
| 04/26/2006 | CN1763101A Antibody of human acidophil chemotactic factor receptor 3 and its preparation method and uses |
| 04/26/2006 | CN1763100A Dipropyl phthalic acid antibody and its preparation method |
| 04/26/2006 | CN1763099A Method for producing monoclonal antibodies |
| 04/26/2006 | CN1763098A Myopodin antibody preparation method |
| 04/26/2006 | CN1763097A Polypeptide variants with altered effector function |
| 04/26/2006 | CN1763096A Animal composite immune globulin production method |
| 04/26/2006 | CN1763095A Yolk immune globulin production method |
| 04/26/2006 | CN1763094A Novel alginate monoclonal antibody and its preparation method and uses |
| 04/26/2006 | CN1762492A CD40 binding molecules and CTL peptides uses in pharmic composition for treating tumors |
| 04/26/2006 | CN1253567C Antihuman seminal specific protein P30 detection reagent strips and monoclone antibody therewith |
| 04/26/2006 | CN1253471C Type CC chemokine-like protein |
| 04/26/2006 | CN1253208C Use of antibodies against CD2O for treatment of graft versus host disease |
| 04/25/2006 | US7034205 Generating genetically engineered plants; obtain cells, incubate with vector, transform cells, propagate plants, screen for miniturized plants |
| 04/25/2006 | US7034137 Isolated mammalian membrane protein genes; related reagents |
| 04/25/2006 | US7034128 Method for recovering proteins from the interstitial fluid of plant tissues |
| 04/25/2006 | US7034127 Hydrophilic biopolymer-drug conjugates, their preparation and use |
| 04/25/2006 | US7034125 Comprises neurotransmitter transport protein for monitoring and evaluating modulators of neuronal signaling; diagnosis and treatment of schizophrenia, epilepsy, depression, learning and neurodegenerative disorders |
| 04/25/2006 | US7034124 Antibodies specific for HLH βcore fragment and uses thereof |
| 04/25/2006 | US7034123 Anti-PRO1347 antibodies |
| 04/25/2006 | US7034122 Nucleotide sequences coding polypeptide for use in the treatment of nervous system and tumor disorders |
| 04/25/2006 | US7034121 Antibodies against CTLA4 |
| 04/25/2006 | US7034120 Method and apparatus for detecting conception in animals |
| 04/25/2006 | US7034114 Polypeptide for use in the treatment of inflammation, atherosclerosis, nervous system, blood, muscular, connective tissue and cancer disorders |
| 04/25/2006 | US7034111 17867, a novel human aminopeptidase |
| 04/25/2006 | US7034108 Mimotopes of hypervariable region 1 of the E2 glycoprotein of HCV and uses thereof |
| 04/25/2006 | US7034105 Endothelial growth factors (Flt4); glycoproteins; tyrosine kinases; immunoglobulins |
| 04/25/2006 | US7033999 Muscle relaxants; anticoagulants; cardiovascular disorders |
| 04/25/2006 | US7033825 Nucleotide sequences coding polypeptide for use in the treatment of nephritis, cancer and kidney disorders |